Population Frequency Distributions of HDL, HDL2, and HDL3 Cholesterol and Apolipoproteins A-I and B in Healthy Men and Women and Associations with Age, Gender, Hormonal Status, and Sex Hormone Use: The Stanford Five City Project
- 31 October 2000
- journal article
- clinical trial
- Published by Elsevier in Preventive Medicine
- Vol. 31 (4), 335-345
- https://doi.org/10.1006/pmed.2000.0715
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular StudyCirculation, 1996
- HDLs Containing Apolipoproteins A-I and A-II (LpA-I:A-II) as Markers of Coronary Artery Disease in Men With Non–Insulin- Dependent Diabetes MellitusCirculation, 1995
- Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies.Circulation, 1994
- Quantitation of Plasma Apolipoproteins in the Primary and Secondary Prevention of Coronary Artery DiseaseAnnals of Internal Medicine, 1994
- Apolipoproteins and ischaemic heart disease: implications for screeningThe Lancet, 1994
- Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.Circulation, 1992
- Levels of Lipids, Lipoproteins, and Apolipoproteins in a Defined PopulationMayo Clinic Proceedings, 1991
- A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial InfarctionNew England Journal of Medicine, 1991
- Potential for increasing high-density lipoprotein cholesterol, subfractions HDL2-C and HDL3-C, and apoprotein Al among middle-age womenPreventive Medicine, 1991
- HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men.Circulation, 1991